Showing results (91-100 of 223) with videos related to

Sort By:
Pageof 23
The Prostate|February 11, 1999
Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1-13.2A C Gao, W Lou, T Ichikawa, et al.
Oncogene|March 17, 2015
CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cellsD J Barakat, J Zhang, T Barberi, et al.
Urologic Oncology|December 8, 2009
Phase I trial with a combination of docetaxel and ¹⁵³Sm-lexidronam in patients with castration-resistant metastatic prostate cancerJianqing Lin, Victoria J Sinibaldi, Michael A Carducci, et al.
Journal of Medicinal Chemistry|April 15, 2005
Applying linear interaction energy method for rational design of noncompetitive allosteric inhibitors of the sarco- and endoplasmic reticulum calcium-ATPasePratap Singh, Anastasiah M Mhaka, Soren B Christensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Delayed micromolar elevation in intracellular calcium precedes induction of apoptosis in thapsigargin-treated breast cancer cellsC Jackisch, H A Hahm, B Tombal, et al.
The Prostate|April 17, 2018
PSA-alpha-2-macroglobulin complex is enzymatically active in the serum of patients with advanced prostate cancer and can degrade circulating peptide hormonesMaya B Kostova, William Nathaniel Brennen, David Lopez, et al.
The Prostate|March 12, 2011
Enzymatically active prostate-specific antigen promotes growth of human prostate cancersSimon A Williams, Christine A Jelinek, Ivan Litvinov, et al.
Stem Cells Translational Medicine|August 3, 2018
Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the PromiseTimothy E G Krueger, Daniel L J Thorek, Samuel R Denmeade, et al.
Journal of Medicinal Chemistry|December 14, 2001
Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cellsC M Jakobsen, S R Denmeade, J T Isaacs, et al.
Cancer Biology & Therapy|March 27, 2004
Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA)Annastasiah Mhaka, Alyssa M Gady, D Marc Rosen, et al.
Pageof 23